SEC Company Response from Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786) (RKTO) — Feb 11, 2019
Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786)
Date: Feb. 11, 2019 · CIK: 0001711786 · Accession: 0001615774-19-002261
AI Filing Summary & Sentiment
File numbers found in text: 333-227772
Show Raw Text
CORRESP
1
filename1.htm
Hoth
Therapeutics, Inc.
1
Rockefeller Plaza, Suite 1039
New
York, New York 10020
February
11, 2019
VIA
EDGAR
United
States Securities and Exchange Commission
100
F Street, N.E.
Washington,
D.C. 20549
Attention: Effie
Simpson
Doug
Jones
Julie
Griffith
Susan
Block
Re: Hoth
Therapeutics, Inc.
Registration Statement on Form S-1, as amended
File No. 333-227772
Ladies
and Gentlemen:
Pursuant
to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Hoth Therapeutics,
Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above
be accelerated so that it will become effective at 5:00 p.m., Eastern Standard Time, on Wednesday February 13, 2019, or as soon
thereafter as possible.
Please
notify Richard Friedman of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3031 as soon
as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.
Thank you,
HOTH THERAPEUTICS, INC.
By: /s/
Robb Knie
Name: Robb
Knie
Title: Chief
Executive Officer